This paper is in the following e-collection/theme issue:

Public (e)Health, Digital Epidemiology and Public Health Informatics (743) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1659) HIV/AIDS/STI Prevention and Care (879) LGBTQ Issues (451)

Published on in Vol 18, No 5 (2016): May

Preexposure Prophylaxis Modality Preferences Among Men Who Have Sex With Men and Use Social Media in the United States

Preexposure Prophylaxis Modality Preferences Among Men Who Have Sex With Men and Use Social Media in the United States

Preexposure Prophylaxis Modality Preferences Among Men Who Have Sex With Men and Use Social Media in the United States

Authors of this article:

Eric William Hall1 Author Orcid Image ;   Walid Heneine2 Author Orcid Image ;   Travis Sanchez1 Author Orcid Image ;   Robert Craig Sineath1 Author Orcid Image ;   Patrick Sullivan1 Author Orcid Image
Article Authors Cited by (25) Tweetations (4) Metrics

Journals

  1. Levy M, Patrick R, Gamble J, Rawls A, Opoku J, Magnus M, Kharfen M, Greenberg A, Kuo I, Colby D. Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis. PLOS ONE 2017;12(8):e0183521 View
  2. Noret M, Balavoine S, Pintado C, Siguier M, Brun A, Bauer R, Loze B, Leplatois A, Aslan A, Moudachirou K, Delaugerre C, Rozenbaum W, Molina J. Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis. AIDS 2018;32(15):2161 View
  3. Patel R, Crane J, López J, Chan P, Liu A, Tooba R, James A, Madiba S. Pre-exposure prophylaxis for HIV prevention preferences among young adult African American men who have sex with men. PLOS ONE 2018;13(12):e0209484 View
  4. Meyers K, Price D, Golub S. Behavioral and social science research to support accelerated and equitable implementation of long-acting preexposure prophylaxis. Current Opinion in HIV and AIDS 2020;15(1):66 View
  5. Zimmermann H, Eekman S, Achterbergh R, Schim van der Loeff M, Prins M, de Vries H, Hoornenborg E, Davidovich U. Motives for choosing, switching and stopping daily or event‐driven pre‐exposure prophylaxis – a qualitative analysis. Journal of the International AIDS Society 2019;22(10) View
  6. Wang Z, Mo P, Ip M, Fang Y, Lau J. Uptake and willingness to use PrEP among Chinese gay, bisexual and other men who have sex with men with experience of sexualized drug use in the past year. BMC Infectious Diseases 2020;20(1) View
  7. Beymer M, Gildner J, Holloway I, Landovitz R. Acceptability of Injectable and On-Demand Pre-Exposure Prophylaxis Among an Online Sample of Young Men Who Have Sex with Men in California. LGBT Health 2018;5(6):341 View
  8. Hambrick H, Park S, Goedel W, Morganstein J, Kreski N, Mgbako O, Duncan D. Rectal Douching Among Men Who Have Sex with Men in Paris: Implications for HIV/STI Risk Behaviors and Rectal Microbicide Development. AIDS and Behavior 2018;22(2):379 View
  9. Kerrigan D, Mantsios A, Grant R, Markowitz M, Defechereux P, La Mar M, Beckham S, Hammond P, Margolis D, Murray M. Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States. AIDS and Behavior 2018;22(11):3540 View
  10. Mgbako O, Park S, Mayer K, Schneider J, Goedel W, Hambrick H, Duncan D. Transactional Sex and Preferences for Pre-Exposure Prophylaxis (PrEP) Administration Modalities Among Men Who Have Sex With Men (MSM). The Journal of Sex Research 2019;56(4-5):650 View
  11. Brooks B, Park S, Guilamo-Ramos V, Schneider J, Harry-Hernandez S, Mgbako O, Dubin S, Duncan D. Sex Tourism and Pre-Exposure Prophylaxis Modality Preferences Among Men Who Have Sex With Men. The Journal of Sex Research 2019;56(4-5):632 View
  12. Meyers K, Rodriguez K, Brill A, Wu Y, La Mar M, Dunbar D, Koblin B, Margolis D, Sobieszczyk M, Van Tieu H, Frank I, Markowitz M, Golub S. Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants. AIDS and Behavior 2018;22(4):1209 View
  13. Torres T, Luz P, De Boni R, de Vasconcellos M, Hoagland B, Garner A, Moreira R, Veloso V, Grinsztejn B. Factors associated with PrEP awareness according to age and willingness to use HIV prevention technologies: the 2017 online survey among MSM in Brazil. AIDS Care 2019;31(10):1193 View
  14. Torres T, De Boni R, de Vasconcellos M, Luz P, Hoagland B, Moreira R, Veloso V, Grinsztejn B. Awareness of Prevention Strategies and Willingness to Use Preexposure Prophylaxis in Brazilian Men Who Have Sex With Men Using Apps for Sexual Encounters: Online Cross-Sectional Study. JMIR Public Health and Surveillance 2018;4(1):e11 View
  15. Goedel W, Schneider J, Hambrick H, Kreski N, Morganstein J, Park S, Mgbako O, Duncan D. Are Anal Sex Roles Associated with Preferences for Pre-Exposure Prophylaxis Administration Modalities Among Men Who Have Sex with Men?. Archives of Sexual Behavior 2018;47(7):2123 View
  16. Zhang J, Xu J, Wang H, Huang X, Chen Y, Wang H, Chu Z, Hu Q, He X, Li Y, Zhang L, Hu Z, Bao R, Li S, Li H, Ding H, Jiang Y, Geng W, Sylvia S, Shang H. Preference for daily versus on‐demand pre‐exposure prophylaxis for HIV and correlates among men who have sex with men: the China Real‐world Oral PrEP Demonstration study. Journal of the International AIDS Society 2021;24(2) View
  17. Chan C, Vaccher S, Fraser D, Grulich A, Holt M, Zablotska-Manos I, Prestage G, Bavinton B. Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia. AIDS and Behavior 2022;26(1):88 View
  18. Stansfield S, Moore M, Boily M, Hughes J, Donnell D, Dimitrov D. Estimating benefits of using on-demand oral prep by MSM: a comparative modeling study of the US and Thailand. eClinicalMedicine 2023;56:101776 View
  19. Philpot S, Murphy D, Chan C, Haire B, Fraser D, Grulich A, Bavinton B. Switching to Non-daily Pre-exposure Prophylaxis Among Gay and Bisexual Men in Australia: Implications for Improving Knowledge, Safety, and Uptake. Sexuality Research and Social Policy 2022;19(4):1979 View
  20. Machicado J, Mounzer R, Paragomi P, Pothoulakis I, Hart P, Conwell D, de-Madaria E, Greer P, Yadav D, Whitcomb D, Lee P, Hinton A, Papachristou G. Rectal Indomethacin Does Not Mitigate the Systemic Inflammatory Response Syndrome in Acute Pancreatitis: A Randomized Trial. Clinical and Translational Gastroenterology 2021;12(11):e00415 View
  21. Stansfield S, Moore M, Boily M, Hughes J, Donnell D, Dimitrov D. Estimating Benefits from Using On-Demand Oral Prep by MSM: A Comparative Modeling Study of the US and Thailand. SSRN Electronic Journal 2022 View
  22. Reyniers T, Fiorentino M, Babo S, Ouedraogo M, Kanta I, Agbegnigan L, Rojas D, Anoma C, Dah T, Mensah E, Keita B, Spire B, Vuylsteke B, Laurent C. The Perceived Added Value of Bimonthly Injectable Pre-Exposure Prophylaxis According to West African Men Who Have Sex with Men: A Focus Group Study. AIDS Patient Care and STDs 2023;37(10):480 View
  23. Okafor C, Eaton L, Watson R. Willingness to Use Long-Acting Injectable PrEP Among PrEP Naïve Black and Hispanic Sexual Gender Minority Persons. AIDS and Behavior 2024;28(6):2166 View
  24. Liu Y, Xian Y, Liu X, Cheng Z, Wei S, Wang J, Chen J, Li C, Ma J, Yang J, Liu F, Yu M, Chen Z, Cui Z. Significant insights from a National survey in China: PrEP awareness, willingness, uptake, and adherence among YMSM students. BMC Public Health 2024;24(1) View
  25. Aldredge A, Carter D, DeCree C, Gardner E, Herring G, Kaabi O, Moges-Banks R, Valencia R, Kelley C, Sullivan P. Preventing Premature PrEP Discontinuation and Sexually Transmitted Infections among Men Who Have Sex with Men: Protocol and Baseline Characteristics of a for Prospective Cohort Study (Project PEACH) (Preprint). JMIR Research Protocols 2024 View